6505--PSMA Prostate Imaging Radiopharmaceuticals Base + 3 OYs 05/01/2026 - 04/30/2030
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Department of Veterans Affairs (VA), specifically Network Contracting Office 12 (NCO 12), has awarded a contract for PSMA Prostate Imaging Radiopharmaceuticals. The award, valued at $739,787.60, was made to PROGENICS PHARMACEUTICALS INC. on April 22, 2026. This contract covers a base period plus three option years, running from May 1, 2026, to April 30, 2030.
Scope of Work
This award pertains to the provision of Prostate Imaging Radiopharmaceuticals, falling under Product Service Code (PSC) 6505 (Drugs And Biologicals) and NAICS Code 325412 (Pharmaceutical Preparation Manufacturing). Specific technical requirements or detailed deliverables are not outlined in the award notice.
Contract Details
- Award Type: Award Notice
- Award Number: 36F79725D0093 36C25226N0395
- Original Solicitation Number: 36C25226Q0351
- Award Amount: $739,787.60
- Award Date: April 22, 2026
- Awardee: PROGENICS PHARMACEUTICALS INC.
- Contract Period: May 1, 2026 – April 30, 2030 (Base + 3 Option Years)
- Set-Aside: None specified
Additional Notes
This award was issued by the VA's Network Contracting Office 12, located in Milwaukee, WI. The Contracting Officer for this action is Stacy Massey (Stacy.Massey@va.gov).